1-4 of 4
Inder M. Verma
Close
Sort by
Journal Articles

Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy

Lili Wang, Roberto Calcedo, Timothy C. Nichols, Dwight A. Bellinger, Aaron Dillow, Inder M. Verma, James M. Wilson
Journal: Blood
Blood (2005) 105 (8): 3079–3086.
https://doi.org/10.1182/blood-2004-10-3867
Published: 2005
Journal Articles

A role for bone marrow–derived cells in the vasculature of noninjured CNS

Brief Report
Francesco Galimi, Robert G. Summers, Henriette van Praag, Inder M. Verma, Fred H. Gage
Journal: Blood
Blood (2005) 105 (6): 2400–2402.
https://doi.org/10.1182/blood-2004-02-0612
Published: 2005
Includes: Multimedia, Supplemental data
Journal Articles

p53 Silencing by Lentiviral Vector Mediated RNA Interference in Murine Hematopoietic Cells and the Development of a Myelogenous Proliferative Disease.

Niels-Bjarne R. Woods, PhD, Vinay Tergaonkar, PhD, Oded Singer, PhD, Virginie Bottero, PhD, Inder M. Verma, PhD
Journal: Blood
Blood (2004) 104 (11): 2572.
https://doi.org/10.1182/blood.V104.11.2572.2572
Published: 2004
Journal Articles

Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors

Francesco Galimi, Meenakshi Noll, Yoshiyuki Kanazawa, Timothy Lax, Cindy Chen, Markus Grompe, Inder M. Verma
Journal: Blood
Blood (2002) 100 (8): 2732–2736.
https://doi.org/10.1182/blood-2002-04-1245
Published: 2002